The right diagnosis,
right away,
at the right price.

We are the creators of Genomtec ID, a mobile platform for genetic diagnosis in the point of patient care.
We have marketed the first SARS-CoV-2 rapid diagnostic kits including the world’s first genetic diagnostic test for the detection of SARS-CoV-2 directly from a saliva sample.

News

2021.11.30

Genomtec’s laboratory genetic test detects all variants of SARS-CoV-2 including Omicron

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the SARS-CoV-2 virus including the recently discovered Omicron variant. Due to growing concerns on ability of IVD tests to recognize newly appearing SARS-CoV-2 variants, Genomtec conducted bioinformatic (in-silico) as well as the wet lab analysis […]

2021.11.29

Genomtec files a new patent application in the UK

Genomtec has filed a patent application entitled “Thermal interface arrangement” for a proprietary method of heat transfer and measurement with the UK Intellectual Property Office (UK IPO). The Issuer’s invention may have broad application not only in diagnostics, but also in biomedical solutions, electronics or mechanics. – Royalties from the potential use of patent-protected inventions […]

2021.11.25

Miron Tokarski Awarded with Laureate of “Leaders of the Future” Ranking by Forbes

Miron Tokarski, co-founder and CEO of Genomtec, found himself among the honourable laureates of the Forbes Magazine ranking: “Leaders of the Future”, organized by the Range Rover brand. Out of 140 nominated candidates the Chapter selected 10 Leaders, visionaries from various fields of life, who in one, five or ten years will be able to […]

Awards